<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To investigate the additional role of MRI contrast enhancement (CE) in the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and the FDG uptake at PET in the <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph-node metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: A model of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> induced by orthotopic HT-29 cells microinjection, producing pelvic <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e>, was assessed using CE-MRI and FDG-PET </plain></SENT>
<SENT sid="2" pm="."><plain>Histology and GLUT-1 immunohistochemistry were performed on <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> and iliac lymph nodes </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">Primary tumors</z:e> were characterized by low FDG-uptake but high CE-MRI, particularly at <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> periphery </plain></SENT>
<SENT sid="4" pm="."><plain>Undetectable FDG-uptake characterized the metastatic lymph-nodes </plain></SENT>
<SENT sid="5" pm="."><plain>Histology revealed large stromal bundles at <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> periphery and a dense network of stromal fibers and neoplastic cells in the inner portion of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Both <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> and positive lymph nodes showed poor GLUT-1 staining </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our data support the complementary role of MRI-CE and FDG PET in some types of <z:mp ids='MP_0002038'>carcinomas</z:mp> characterized by abundant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-associated stroma and poor FDG avidity consequent to poor GLUT-1 transported </plain></SENT>
<SENT sid="8" pm="."><plain>In these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> FDG-PET alone may be not completely adequate to obtain an adequate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> radiotherapy planning, and a combination with dual CE-MRI is strongly recommended </plain></SENT>
</text></document>